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A 56-year-old was referred to a gynecologic oncologist after an initial
work-up for hematuria and postmenopausal bleeding for greater than
two years revealed a 30 × 15 cm complex cystic mass in the pelvis. She
had no other complaints at presentation, speciﬁcally denying abdominal
pain, changes in appetite, satiety, and bowel habits. She had a medical
history signiﬁcant for chronic obstructive pulmonary disease but was
otherwise uncomplicated. Family historywasnegativewith the exception
of an unknown type of cancer in her sister.Introduction
Cotyledonoid dissecting leiomyoma (CDL) is a rare benign uterine
tumor initially recognized in 1975 that presents clinically and radiologi-
cally as an apparent malignant growth (Roth et al., 1996). The age distri-
bution ranges from 23 to 73 years (Smith et al., 2012). Typical presenting
symptoms are those characteristic for pelvicmasses, including abdominal
pain, bloating, constipation andweight gain; themost commonpresenta-
tion is abnormal uterine bleeding, as seen in this case (Smith et al., 2012).
On ultrasound, these masses appear more lobulated and bulky than typi-
cal leiomyoma (Smith et al., 2012). CDL is a leiomyoma variant which
shows a dissecting pattern, seen histologically as smooth-muscle tumors
with microscopic tongues of tumoral tissue extending at least 5 mm be-
tween fascicles of the myometrium adjacent to the dominant mass
(Roth et al., 1996). CDL is grossly characterized by a reddish placenta-
like appearance and its tendency to expand beyond the pelvic cavity
into the abdomen (Smith et al., 2012). To date, there have been fewer
than 50 cases of CDL reported in the English literature based on a PubMed
search. This case represents only the second reported tumor displaying
adipocytic differentiation (lipoleiomyoma) (Fukunaga et al., 2010).s and Gynecology, University
fﬁce 1, Room 4010, 12631 E.
.
. This is an open access article underOn physical exam, shewas noted to have a normal cervix and vagina.
She had a palpable pelvic mass extending from pelvis to umbilicus.
Transvaginal ultrasound revealed a heterogeneous probable soft tissue
mass without discernable uterus. Ovaries were not identiﬁed, and
there was no free ﬂuid in the cul-de-sac. Abdominal and pelvic comput-
erized tomography showed a very large pelvic mass measuring at least
25× 30×15 cmarising from the right adnexa and extending into the ab-
domen, displacing the surrounding structures. The cephalad extent of
tumor was at the L2–L3 disc level. Tumor markers, including CA 125,
CEA, and CA 19-9 were within normal limits.
The patient underwent an exploratory laparotomy, total abdominal
hysterectomy, bilateral salpingo-oophorectomy, radical tumor debulking,
resection of right and left sided retroperitoneal masses, right sided com-
plete ureterolysis, extensive lysis of adhesions, infracolic omentectomy,
and diagnostic cystoscopy. At time of the procedure, the mass was noted
tobea large approximately 26 cmuteruswith the extrauterine component
continuous with the corpus. The extrauterine component consisted of
large bilateral extensions of the mass from the uterus into the
retroperitoneum and pelvic sidewall, the right side being 15 × 20 cm
and the left 10 × 8 cm. Extraction of the entirety of themass took approx-
imately 6 h due to dense adhesions and its large nature. The mass was
noted to be soft and spongy. Multiple intraoperative frozen sections
were diagnosed as smooth muscle neoplasm without cytologic atypia.
The mass was highly vascular, and transfusion of one unit of packed red
blood cells was required during the procedure. At the end of the case, no
visible tumor remained.
Tissue analysis was performed by a board certiﬁed pathologist with
specialization in gynecologic pathology. On gross examination, multiple
specimens containing tumor measured 84 cm in aggregate. Tumor
involving the surface of the uterus had a lobulated, red appearance
(Fig. 1a). Microscopically the tumor was composed of cytologicallythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. a. Gross photograph of uterine serosa showing red bulbous protrusions with a “placenta-like” appearance. b. Bland fascicles of smooth muscle dissecting into the background
myometrium with a pushing border in multiple areas (1× magniﬁcation, hematoxylin and eosin stain). c. Background of smooth muscle cells with foci of embedded adipose tissue
(arrow) showing positive staining for S100. To the left, an occluded vessel with prominent atherosis of the wall is indicated (*) (4× magniﬁcation, S100 stain). d. Lymphovascular
space invasion, as demonstrated by a nodule of smooth muscle tumor with hemorrhage sitting within a vascular space (4× magniﬁcation, hematoxylin and eosin stain).
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into the surrounding myometrium (Fig. 1b). Cytologic atypia, increased
mitotic activity and tumor-cell necrosis were not seen despite extensive
sampling. Immunohistochemical staining showed lesional cells to be
positive for SMA and negative for HMB-45, with a Ki-67 index of b1%.
Multiple areas of the tumor showed collections of cells with adipocytic
differentiation, conﬁrmed by an S100 stain (Fig. 1c). Extensive atherosis
and thrombosis of intratumoral blood vessels were noted, as well as
focal lymphovascular space invasion (Fig. 1d). The ﬁnal diagnosis was
cotyledonoid dissecting lipoleiomyoma with focal vascular invasion.
The patient was discharged from the hospital without complications
5 days following surgery and was healing well without evidence of
recurrence 2 months post-surgery (Fig. 2).Fig. 2. Pre-operative CT scan.Discussion
CDL presents in a manner that causes concern for malignancy based
on gross and radiological appearance; however, it is a benign smooth
muscle neoplasm with a growth pattern characterized by inﬁltrative
intramural dissection within the uterine corpus and often a placental-
like appearance macroscopically in its extrauterine component (Roth
et al., 1996). The tumors typically present as a multinodular dissecting
uterine mass with or without extrauterine extension, including to the
broad ligament, adnexa and retroperitoneum. In most cases, there is
some connection found between the uterine and extra-uterine disease.
Due to the aggressive growth and extension of these masses, the differ-
ential diagnosis may include hydropic leiomyoma, leiomyoma with
perinodular hydropic degeneration, myxoid leiomyoma, intravenous
leiomyomatosis, low-grade endometrial stromal sarcoma, perivascular
epithelioid cell tumors, and leiomyosarcoma (Smith et al., 2012).
Histologically, CDL is composed of benign smooth muscle. Charac-
teristics observed in typical leiomyomas such as edema, hydropic
change, focal hemorrhage, hyalinization and occasional abnormal nuclei
without associated mitotic activity can also be seen in CDL, as was
observed in our case. Approximately 20% of cases are reported to have
an intravascular component, including vascular invasion present in
the myometrial mass; however, this is not believed to change the
benign clinical course (Smith et al., 2012). Over 90% of cases include
a dissecting component consisting of inﬁltrating, sinus-like tongues
extending for at least 5 mm into the surrounding tissue (Smith et al.,
2012). All cases reported to date have been clinically benign despite
concerning pathological prognostic factors such as lymphovascular
invasion (Smith et al., 2012; Roth et al., 2013).
While the vast majority of reported cases are composed of purely
smooth muscle cells, there is one reported case of a tumor displaying
adipocytic differentiation (lipoleiomyoma) in the literature (Smith et al.,
2012; Fukunaga et al., 2010). In addition to this ﬁnding, our case was
also notable for extensive atherosis and thrombosis of intratumoral ves-
sels. This ﬁnding has not been previously reported and is of uncertain
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atherosis refers to lipid-ﬁlled macrophages that accumulate in the spiral
arteries of the uteroplacental circulation. Atherosis in pregnancy is associ-
atedwith preeclampsia and is considered to be a signof defective vascular
remodeling (Staff et al., 2013).
Although widely reported to be without potential for metastasis or
recurrence, there has been one recently reported case of recurrent CDL
following myomectomy (Roth et al., 2013). While this case was classi-
ﬁed as a recurrence, incomplete resection with regrowth of persistent
disease should always be taken into consideration. Literature review
indicates that 24 patientswere treatedwith total hysterectomy accompa-
nied by unilateral or bilateral salpingo-oophorectomy, and 13 cases
received a hysterectomy with ovarian preservation, all without evidence
of recurrence (Smith et al., 2012; Chawla et al., 2014; Geynisman et al.,
2014). Eight patients were treated with tumor resection alone with one
documented recurrence (Smith et al., 2012; Roth et al., 2013; Tanaka
et al., 2013). The one patient with recurrent disease underwent a subse-
quent total abdominal hysterectomy and right salpingo-oophorectomy
without evidence of disease 2.5 years after the second surgery (Roth
et al., 2013).
While CDL is a rare clinical entity, it is important that both surgeons
and pathologists be aware of its characteristics in order to avoid over-
treatment. In addition to the typical macroscopic appearance de-
scribed above, radiologic characteristics of CDL include T2-weighted
MRI images that are less heterogenous than sarcomatous lesions, and
images isointense to myometrium on T1-weighted imaging. Ultrasound
images, however, are not speciﬁc (Smith et al., 2012). Both macroscopic
and radiological features are distinctive enough to suggest CDL in the
initial evaluation or the operating room, and, despite the aggressive
appearance of the tumor, a benign process should be considered in thedifferential when confronted with a lesion of this nature. While recur-
rence is exceedingly rare, treatment decisions should be informed by
the fact that there has been a likely recurrence documented after conser-
vative treatment.
This case presentation adds to the literature by documenting an
extremely rare case of an aggressive appearing but benign entity.
Although rare, cotyledonoid dissecting lipoleiomyoma should be in
the differential when a suspected malignancy of the uterine corpus
is encountered.
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